PharmMedPolis: Medical Probe

2022: Release of medical probes for herpes search for 75 million rubles

Pharmmedpolis RT has launched a medical probe in Tatarstan to diagnose the Epstein-Barr human herpes virus. Funds for the creation of a new production in the amount of 75 million rubles were provided by the Industrial Development Fund (FRP), which his press service announced on September 26, 2022.

The company plans to produce 600 thousand oropharyngeal probes per year, including to identify the DNA of the Epstein-Barr virus. The product takes into account the peculiarities of the virus localization and the physiological structure of the biomaterial intake area, according to the FRP.

"Pharmmedpolis RT" launched in Tatarstan the production of medical probes for the diagnosis of human herpes virus

According to the developers, the new probes have patented innovative characteristics that allow for a highly accurate research result. It takes into account the peculiarities of the virus localization and the physiological structure of the biomaterial intake area. The probe is easily inserted into the oral cavity reaching the back wall of the pharynx, quickly takes the biomaterial and then easily gives it to the environment for further investigation, the manufacturer says.

According to Farmedpolis RT estimates, by September 2022, about 50% of the Russian market for probes for detecting herpes viruses is occupied by products from foreign manufacturers, mainly from the USA and Italy. New production in Tatarstan will significantly reduce the share of imports, the company expects.

{{quote 'Epstein-Barr virus is the most common virus on the planet. Its carriage reaches 95% among all people on Earth. This virus is considered the main culprit in the development of infectious mononucleosis and tumors, - said Albert Gayfullin, General Director of Farmmedpolis RT. }} Type IV herpes virus is spread by airborne droplets with the saliva particles of an infected person and causes infectious mononucleosis.^[1]

Notes